Bioventus Inc - Ordinary Shares - Class A

NASDAQ:BVS   1:00:00 PM EDT
2.45
+0.26 (+11.87%)
: $2.38 -0.07 (-2.86%)
Other Pre-Announcement

Bioventus Reports Third Quarter Results

Published: 11/08/2022 13:18 GMT
Bioventus Inc - Ordinary Shares - Class A (BVS) - Bioventus Reports Third Quarter Results; Updates Full-year 2022 Financial Guidance.
Q3 Sales Rose 25.9 Percent to $137.1 Million.
Sees FY 2022 Net Sales of $527 Million to $532 Million.
Sees FY 2022 Non-GAAP Eps* of $0.20 to $0.25.
Qtrly Basic Earnings per Share of Class A Common Stock of $0.03.
Qtrly Non-GAAP Earnings per Share of Class A Common Stock of $0.08.
Sees FY 2022 Net Sales of $527 Million to $532 Million.
Q3 Earnings per Share View $0.12, Revenue View $141.6 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $0.51, Revenue View $553.9 Million -- Refinitiv Ibes Data (analyst estimates).